| Denise Hunter, MD | |
|
1010 N Washington St, Janesville, WI 53548-1561 | |
| (608) 741-2430 | |
| Not Available |
| Full Name | Denise Hunter |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 1010 N Washington St, Janesville, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184663320 | NPI | - | NPPES |
| 34440700 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 46424 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Denise Hunter, MD 370a Whitewater Dr, Bolingbrook, IL 60440-7973 Ph: (630) 226-4675 | Denise Hunter, MD 1010 N Washington St, Janesville, WI 53548-1561 Ph: (608) 741-2430 |
News Archive
The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.
Tessera, Inc., a Seattle-based biomedical company, has released its first product, ProstaMark EPCA (Early Prostate Cancer Antigen), as an Analyte Specific Reagent (ASR) for commercial use in pathology laboratories to assist pathologists in their efforts to determine if cancer is present in the prostate.
In a new study posted to the bioRxiv* preprint server, researchers from the United States report that two iminosugar glucosidase inhibitors have the ability to suppress the replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in tissue culture – at concentrations of at least 100 times lower than required for cytotoxic effects.
› Verified 4 days ago
Imdad Ahmed, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6868 Fax: 608-756-6289 | |
Jacob A Thomas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6741 Fax: 608-756-6376 | |
David R. Isaacson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6261 Fax: 068-756-6236 | |
Dr. Fahim Haider Jafary, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6868 | |
Kauseruzzaman A. Khan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3524 E Milwaukee St, Janesville, WI 53546 Phone: 608-756-7100 Fax: 608-741-4700 | |
William N Brandt, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000 Fax: 608-371-8277 | |
Kathryn A Lilley, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000 Fax: 608-371-8939 |